Announcements Trials
Browse Landscape

Status

No longer available 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 54Observational 9Expanded_access 2

Sponsor

Cancer Type

Other solid neoplasm 1Genitourinary 1

Conditions

Solid Tumors 1Carcinoma, Renal Cell 1

Interventions

nilotinib 5dabrafenib 4Nivolumab 4Afatinib 4trametinib 3regorafenib 3midostaurin 3elotuzumab 3TIC10 compound 3Sunitinib 3Prednisone 3Capecitabine 3Abiraterone Acetate 33-Iodobenzylguanidine 3venetoclax 2tucatinib 2tempol 2tazemetostat 2talquetamab 2talimogene laherparepvec 2ruxolitinib 2pomalidomide 2olaparib 2niraparib 2leronlimab 2lenvatinib 2ibrutinib 2gilteritinib 2ceritinib 2brexucabtagene autoleucel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Expanded_access × Axitinib × Clear all
NCT02354612 2021-02-15

Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial

Tracon Pharmaceuticals Inc.

No longer available
Other solid neoplasm

Solid Tumors

NCT01473043 2014-05-30

Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment

Pfizer

No longer available
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡